Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Friday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE:AMPE opened at $0.00 on Friday. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $7.47. The company has a market cap of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. The firm has a 50 day simple moving average of $0.02 and a 200 day simple moving average of $0.37.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.